Preliminary reports reveal conolidine may well inhibit distinct ion channels, cutting down neuronal excitability and limiting ache signals. This system is particularly suitable in neuropathic ache, where by irregular signaling results in persistent distress. Additionally, conolidine appears to influence G protein-coupled receptor (GPCR) pathways in